The latest news
Bayer leads in sustainability
Bayer: Challenging third quarter – Group outlook confirmed
Bayer: Solid performance despite COVID-19 impact
Bayer completes the sale of its Animal Health business unit to Elanco
Bayer: Good start to 2020 – activities marked by COVID-19
Explore Our Businesses
We are addressing some of the most urgent global challenges by constantly developing new solutions. The global population is steadily growing and aging so it requires better medicines and a sufficient quantity of high-quality food.